During the last 15 years of his more than 25 years in the industry, Alexander held C-level positions at leading global companies as Sun Pharmaceuticals and Merz Pharmaceuticals. Alexander is also co-founder and Executive Chairman of US-based Galimedix Therapeutics. Alexander studied medicine at Gutenberg University in Mainz, Germany where he gained his doctor´s degree in experimental pharmacology. He also holds a degree in computer science and lectures pharmacoeconomics.

After graduating from Oxford University, Jonas joined Goldman Sachs’ Principal Investment Area, where he worked on a number of private equity transactions for the Goldman Sachs Capital Partners family of funds. Before working at Secarna, he founded an investment management company in Berlin and served as Managing Director for sterna biologicals.

Additionally, he worked for Och-Ziff Capital Management, where his responsibilities included special situations and equity long/short investments. Jonas holds a degree in Philosophy, Politics, and Economics from Oxford University.

He also served as Chief Business Officer for Activaero, a German-American respiratory company, where he helped grow their commercial functions and played an instrumental role in the company’s trade sale in 2014.

Christian worked as an adjunct professor at Webster University in Vienna, Austria, where he gave lectures on Marketing Strategy & Execution. He holds a Bachelor’s degree in Business Administration and a Master’s degree in International Business from Webster University.

Frank’s therapeutic expertise is rooted in the fields of oncology and metabolic diseases. He has profound knowledge in conceptualizing, developing and evaluating ASO-based, targeted therapies, playing a central role in establishing new, high value ASO pipelines in the course of his career. Before joining Secarna, Frank worked in scientific leadership positions at Antisense Pharma/Isarna Therapeutics and The Genetics Company.

Frank is an active contributor to the international scientific and biopharmaceutical discovery and development community and his and his team’s work is recognized at international conferences and in major peer-reviewed publications.